GW0742 Raw Material Powder For Bodybuilding CAS:317318-84-6
GW0742 is a potent PPARδ agonist classified as a research chemical and is not intended for human consumption, diagnostic use, or as a therapeutic agent. It is not a dietary supplement, nor is it approved by any major regulatory body like the FDA for human use. Handling raw material powders requires specialized laboratory equipment and expertise. This document does not endorse or encourage the use of this compound in humans and explicitly outlines the significant risks involved.
What is GW0742 Raw Material Powder?
GW0742 is a high-purity, synthetic agonist for the Peroxisome Proliferator-Activated Receptor Delta (PPARδ). It is supplied as a raw material powder, typically appearing as a white to off-white crystalline solid, intended solely for controlled laboratory research. Its primary application in scientific study is to investigate the complex signaling pathways of PPARδ and its profound effects on lipid metabolism, energy homeostasis, and cellular function in model organisms and in vitro systems.
Chemically, it is known as [(2-Methyl-4-((4-methyl-2-(4-(trifluoromethyl)phenyl)-1,3-thiazol-5-yl)methylthio)phenoxy)acetic acid]. It was originally developed by pharmaceutical giant GlaxoSmithKline (GSK) as a potential therapeutic agent for metabolic diseases like dyslipidemia and type 2 diabetes due to its powerful lipid-modulating effects. However, its development for human pharmaceuticals was halted, and it remains a tool for preclinical research.
The "raw material powder" designation indicates it is the unformulated, pure active pharmaceutical ingredient (API). This form is handled in laboratory settings for in vitro assays (e.g., cell culture studies) or for formulating into solutions for animal model research, always adhering to strict ethical and safety guidelines.
Features and Mechanism of Action
The defining feature of GW0742 is its exceptional potency and selectivity as a PPARδ agonist. Its mechanism of action is highly specific:
●High Selectivity for PPARδ: It binds to and activates the PPARδ receptor with an affinity significantly greater than for the other PPAR subtypes (PPARα and PPARγ). This selectivity is crucial for researchers isolating the effects mediated specifically through the δ receptor pathway.
●Transcriptional Regulation: Upon activation, PPARδ forms a heterodimer with the Retinoid X Receptor (RXR). This complex then binds to specific DNA sequences known as Peroxisome Proliferator Response Elements (PPREs) in the promoter regions of target genes. This binding upregulates or downregulates the transcription of these genes.
●Key Target Genes: The genes regulated are primarily involved in fatty acid uptake, transport, oxidation (burning), and energy expenditure. Essentially, GW0742 activation of PPARδ signals the body to shift its primary energy source from glucose to lipids.
Primary Research Features:
●Potent Lipid Catabolism Inducer: Forces a metabolic switch to favor fat as fuel.
●Mitochondrial Biogenesis Stimulator: Promotes the creation of new mitochondria, the power plants of cells, enhancing endurance and stamina in research models.
●Insulin Sensitizer: Improves glucose disposal and insulin sensitivity in muscle tissue.
●Raw Purity: As a raw powder, it is characterized by a high degree of chemical purity (>98% or >99%), which is essential for obtaining consistent and reproducible experimental results.
Applications in Research Context
In a legitimate research environment, GW0742 powder is not used for "bodybuilding" but to study metabolic pathways. Its applications in science include:
●Metabolic Disease Research: Investigating potential mechanisms for treating atherosclerosis, metabolic syndrome, and type 2 diabetes by studying its effects on reversing cholesterol transport and improving lipid profiles.
●Exercise Physiology and Endurance Studies: Research on transgenic animals or cell models has shown that PPARδ activation can dramatically increase the proportion of fatigue-resistant, oxidative (type I) muscle fibers. This makes it a valuable tool for studying the genetic and molecular basis of endurance and physical performance.
●Skeletal Muscle Biology: Studying the regulation of muscle fiber type switching, mitochondrial function, and the overall adaptive response of muscle to metabolic stimuli.
●Cancer Cell Metabolism: Some research areas explore how cancer cells alter their metabolism (the Warburg effect) and how PPARδ modulation might affect tumor growth and proliferation.
Hypothesized Benefits (From Preclinical Data)
It is critical to understand that the following "benefits" are extrapolations from rodent studies and in vitro research. Their translation to humans is unproven, and the risks are substantial.
●Dramatic Increase in Endurance: Rodent studies demonstrated a phenomenal increase in running endurance (up to 70% longer duration) without prior training, attributed to the fiber type switch and enhanced mitochondrial capacity.
●Promotion of Lipid Oxidation (Fat Loss): By reprogramming metabolism to preferentially burn fat for energy, a significant reduction in adipose tissue is observed in research models, even without a change in diet or activity level.
●Improved Lipid Profile: Research indicates GW0742 can lower levels of triglycerides and LDL (bad) cholesterol while raising HDL (good) cholesterol, suggesting a potent cardioprotective effect in animal models.
●Enhanced Insulin Sensitivity: It promotes glucose uptake into skeletal muscle, improving overall metabolic health parameters in research subjects.
Dosage, Half-Life, and Administration in Research
Important Note: There is no established safe or effective human dosage. The following is based on extrapolations from peer-reviewed animal research and is presented for informational purposes only.
●Dosage (Research Context): In murine studies, effective oral doses are typically in the range of 1 to 10 mg per kilogram of body weight, administered daily. For a human equivalent dose calculation, this translates to a very low milligram range. However, human response can be drastically different.
●Half-Life: The half-life of GW0742 in research models is estimated to be relatively long, potentially between 12 to 24 hours. This suggests that a once-daily administration protocol would be sufficient to maintain stable plasma concentrations in a research setting.
●Administration: In the lab, the raw powder must be carefully suspended or dissolved using appropriate solvents (e.g., dimethyl sulfoxide (DMSO) for in vitro work or a carboxymethyl cellulose (CMC) solution for oral gavage in animals) to ensure accurate and consistent dosing.
Research Cycle Protocol
A "cycle" in a research context refers to the duration of a controlled experiment. A typical in vivo study might last from 4 to 12 weeks to observe the full genomic and phenotypic effects of sustained PPARδ activation. Longer cycles are associated with a higher probability of observing adverse effects, which is a critical part of the compound's safety profiling.
Post-Therapy Care (PTC) / Post-Cycle Therapy (PCT)
This is a critical differentiator from anabolic steroids. GW0742 does not suppress the hypothalamic-pituitary-testicular (HPT) axis. It does not cause testosterone shutdown or estrogen-related side effects like gynecomastia. Therefore, a traditional PCT (using SERMs like Clomid or Nolvadex) is not required after discontinuing research with GW0742.
However, the concept of "PTC" here should be reinterpreted as "Post-Research Recovery." The primary concern is the potential long-term metabolic adaptation. After ceasing administration, the research subject's metabolism would gradually revert to its baseline state. A key area of study would be whether the induced changes (e.g., fiber type switching) are permanent or reversible upon cessation.
Clinical Data
|
Trade names |
GW0742,GW610742 , Fitorine |
|
CAS |
317318-84-6 |
|
Molar mass |
471.48 |
|
MF |
C21H17F4NO3S2 |
|
Purity |
Above 98% |
|
Apprarance |
White Cyrstalline Powder |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-15871669785
Conclusion
GW0742 raw material powder is a powerful and selective research chemical that has provided profound insights into metabolic regulation and endurance in preclinical models. Its ability to activate PPARδ and fundamentally alter energy metabolism has made it a valuable, albeit strictly controlled, scientific tool.
Hot Tags: gw0742 raw material powder for bodybuilding cas:317318-84-6, China gw0742 raw material powder for bodybuilding cas:317318-84-6 manufacturers, suppliers, factory, LGD4033 Treat Muscular Dystrophy and Osteoporosis, AC-262, Andarine S4 Build muscle, OTR-AC, GW0742, S23
